Vivace

  1. NAME OF THE MEDICINAL PRODUCT

 

Vivace 30 mg/10 mg tablets.

 

 

  1. QUALITATIVE AND QUANTITATIVE COMPOSITION

 

Each tablet contains 30 mg of delapril hydrochloride and 10 mg of manidipine hydrochloride.

Excipients: 67.60 mg of lactose monohydrate/tablet.

0.08 mg of aluminium lake E110 (orange yellow)/tablet.

 

 

  1. PHARMACEUTICAL FORM

 

Slotted round tablet pink salmon.

 

4. INDICATIONS

 

Treatment of essential hypertension.
The fixed combination Vivace (30 mg / 10 mg) is indicated in patients whose blood pressure is not adequately controlled with delapril or manidipine alone.



5. CLASSIFICATION FOR SUPPLY SYSTEM

 

Medicinal product subject to medical prescription. Repayable by the National Health System: Normal Contribution Vivace 30 mg / 10 mg package containing 28 tablets PVP IVA: 21.07 €.